Deep learning prediction of hospital readmissions for asthma and COPD
- PMID: 38093373
- PMCID: PMC10720134
- DOI: 10.1186/s12931-023-02628-7
Deep learning prediction of hospital readmissions for asthma and COPD
Abstract
Question: Severe asthma and COPD exacerbations requiring hospitalization are linked to increased disease morbidity and healthcare costs. We sought to identify Electronic Health Record (EHR) features of severe asthma and COPD exacerbations and evaluate the performance of four machine learning (ML) and one deep learning (DL) model in predicting readmissions using EHR data.
Study design and methods: Observational study between September 30, 2012, and December 31, 2017, of patients hospitalized with asthma and COPD exacerbations.
Results: This study included 5,794 patients, 1,893 with asthma and 3,901 with COPD. Patients with asthma were predominantly female (n = 1288 [68%]), 35% were Black (n = 669), and 25% (n = 479) were Hispanic. Black (44 vs. 33%, p = 0.01) and Hispanic patients (30 vs. 24%, p = 0.02) were more likely to be readmitted for asthma. Similarly, patients with COPD readmissions included a large percentage of Blacks (18 vs. 10%, p < 0.01) and Hispanics (8 vs. 5%, p < 0.01). To identify patients at high risk of readmission index hospitalization data of a subset of 2,682 patients, 777 with asthma and 1,905 with COPD, was analyzed with four ML models, and one DL model. We found that multilayer perceptron, the DL method, had the best sensitivity and specificity compared to the four ML methods implemented in the same dataset.
Interpretation: Multilayer perceptron, a deep learning method, had the best performance in predicting asthma and COPD readmissions, demonstrating that EHR and deep learning integration can improve high-risk patient detection.
© 2023. The Author(s).
Conflict of interest statement
Dr. Gomez is a former associate editor of Respiratory Research.
Figures
Similar articles
-
Using Machine Learning to Predict Likelihood and Cause of Readmission After Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation.Int J Chron Obstruct Pulmon Dis. 2022 Oct 20;17:2701-2709. doi: 10.2147/COPD.S379700. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36299799 Free PMC article.
-
Sex and racial/ethnic differences in the reason for 30-day readmission after COPD hospitalization.Respir Med. 2017 Oct;131:6-10. doi: 10.1016/j.rmed.2017.07.056. Epub 2017 Jul 25. Respir Med. 2017. PMID: 28947044 Free PMC article.
-
Development of Multivariable Prediction Models for the Identification of Patients Admitted to Hospital with an Exacerbation of COPD and the Prediction of Risk of Readmission: A Retrospective Cohort Study using Electronic Medical Record Data.COPD. 2023 Dec;20(1):274-283. doi: 10.1080/15412555.2023.2242493. COPD. 2023. PMID: 37555513
-
Management of chronic obstructive pulmonary disease: A review focusing on exacerbations.Am J Health Syst Pharm. 2020 Feb 7;77(4):259-268. doi: 10.1093/ajhp/zxz306. Am J Health Syst Pharm. 2020. PMID: 31930287 Free PMC article. Review.
-
The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives.Expert Rev Respir Med. 2012 Feb;6(1):117-27. doi: 10.1586/ers.12.2. Expert Rev Respir Med. 2012. PMID: 22283584 Review.
Cited by
-
Predicting COPD exacerbations based on quantitative CT analysis: an external validation study.Front Med (Lausanne). 2024 Jun 12;11:1370917. doi: 10.3389/fmed.2024.1370917. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38933101 Free PMC article.
References
-
- James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7. - DOI - PMC - PubMed
-
- Sadatsafavi M, Sin DD, Zafari Z, Criner G, Connett JE, Lazarus S, et al. The association between rate and severity of exacerbations in chronic obstructive pulmonary disease: an application of a joint frailty-logistic model. Am J Epidemiol. 2016;184:681–689. doi: 10.1093/aje/kww085. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
